Ledger.Open graph →

SEC Form D · filed March 14, 2016

BioAegis Therapeutics, Inc

Offering

$5.0M

Sold

$1.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

North Brunswick, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Thomas Stossel · North Brunswick, NJExec · Director Susan Levinson · North Brunswick, NJExec · Director Valerie Ceva · North Brunswick, NJExec · Director Dana B. Mcgowan · San Diego, CAExec · Director Jon D. Elias · Coral Gables, FLExec · Director Jarryd D. Levine · Greenwich, CTExec · Director Steven Cordovano · Rowayton, CTExec David F. Hale · San Diego, CAExec · Director Brian B. Lannutti · San Diego, CAExec · Director Michael E. Coyle · San Ramon, CAExec · Director Steven Cordovano · North Brunswick, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗